Yale University is testing adalimumab for the progression of Parkinson's disease.
2 reports, 1 independent
Updated Sep 19
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Yale University is testing adalimumab for the progression of Parkinson's disease.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Yale University
private university in New Haven, Connecticut